223 related articles for article (PubMed ID: 26095774)
1. RANK Ligand Modulation of Autophagy in Oral Squamous Cell Carcinoma Tumor Cells.
Sambandam Y; Sakamuri S; Balasubramanian S; Haque A
J Cell Biochem; 2016 Jan; 117(1):118-25. PubMed ID: 26095774
[TBL] [Abstract][Full Text] [Related]
2. Autoregulation of RANK ligand in oral squamous cell carcinoma tumor cells.
Sambandam Y; Ethiraj P; Hathaway-Schrader JD; Novince CM; Panneerselvam E; Sundaram K; Reddy SV
J Cell Physiol; 2018 Aug; 233(8):6125-6134. PubMed ID: 29323724
[TBL] [Abstract][Full Text] [Related]
3. RANKL triggers resistance to TRAIL-induced cell death in oral squamous cell carcinoma.
Ethiraj P; Sambandam Y; Hathaway-Schrader JD; Haque A; Novince CM; Reddy SV
J Cell Physiol; 2020 Feb; 235(2):1663-1673. PubMed ID: 31309556
[TBL] [Abstract][Full Text] [Related]
4. Tanshinone IIA induces cell death via Beclin-1-dependent autophagy in oral squamous cell carcinoma SCC-9 cell line.
Qiu Y; Li C; Wang Q; Zeng X; Ji P
Cancer Med; 2018 Feb; 7(2):397-407. PubMed ID: 29316373
[TBL] [Abstract][Full Text] [Related]
5. Role of CXC chemokine ligand 13 in oral squamous cell carcinoma associated osteolysis in athymic mice.
Pandruvada SN; Yuvaraj S; Liu X; Sundaram K; Shanmugarajan S; Ries WL; Norris JS; London SD; Reddy SV
Int J Cancer; 2010 May; 126(10):2319-29. PubMed ID: 19816883
[TBL] [Abstract][Full Text] [Related]
6. The inhibition of RANKL/RANK signaling by osteoprotegerin suppresses bone invasion by oral squamous cell carcinoma cells.
Shin M; Matsuo K; Tada T; Fukushima H; Furuta H; Ozeki S; Kadowaki T; Yamamoto K; Okamoto M; Jimi E
Carcinogenesis; 2011 Nov; 32(11):1634-40. PubMed ID: 21890459
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of autophagy augments apoptosis in human oral squamous cell carcinoma under nutrient depletion.
Jiang LC; Xin ZY; Deborah B; Zhang JS; Yuan DY; Xu K; Liu XB; Jiang HQ; Fan QC; Zhang B; Li KY
J Oral Pathol Med; 2015 May; 44(5):361-6. PubMed ID: 25212667
[TBL] [Abstract][Full Text] [Related]
8. Selective inhibition of NF-κB suppresses bone invasion by oral squamous cell carcinoma in vivo.
Furuta H; Osawa K; Shin M; Ishikawa A; Matsuo K; Khan M; Aoki K; Ohya K; Okamoto M; Tominaga K; Takahashi T; Nakanishi O; Jimi E
Int J Cancer; 2012 Sep; 131(5):E625-35. PubMed ID: 22262470
[TBL] [Abstract][Full Text] [Related]
9. CXCL13 activation of c-Myc induces RANK ligand expression in stromal/preosteoblast cells in the oral squamous cell carcinoma tumor-bone microenvironment.
Sambandam Y; Sundaram K; Liu A; Kirkwood KL; Ries WL; Reddy SV
Oncogene; 2013 Jan; 32(1):97-105. PubMed ID: 22330139
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of H3K9 methyltransferase G9a induces autophagy and apoptosis in oral squamous cell carcinoma.
Ren A; Qiu Y; Cui H; Fu G
Biochem Biophys Res Commun; 2015 Mar; 459(1):10-7. PubMed ID: 25634693
[TBL] [Abstract][Full Text] [Related]
11. High LC3 expression correlates with poor survival in patients with oral squamous cell carcinoma.
Tang JY; Hsi E; Huang YC; Hsu NC; Chu PY; Chai CY
Hum Pathol; 2013 Nov; 44(11):2558-62. PubMed ID: 24055091
[TBL] [Abstract][Full Text] [Related]
12. Secretion of IL-6 and IL-8 from lysophosphatidic acid-stimulated oral squamous cell carcinoma promotes osteoclastogenesis and bone resorption.
Hwang YS; Lee SK; Park KK; Chung WY
Oral Oncol; 2012 Jan; 48(1):40-8. PubMed ID: 21925926
[TBL] [Abstract][Full Text] [Related]
13. Autophagy regulated by prolyl isomerase Pin1 and phospho-Ser-GSK3αβ involved in protection of oral squamous cell carcinoma against cadmium toxicity.
So KY; Ahn SG; Oh SH
Biochem Biophys Res Commun; 2015 Oct; 466(3):541-6. PubMed ID: 26381174
[TBL] [Abstract][Full Text] [Related]
14. Establishment of a xenograft model to explore the mechanism of bone destruction by human oral cancers and its application to analysis of role of RANKL.
Tohyama R; Kayamori K; Sato K; Hamagaki M; Sakamoto K; Yasuda H; Yamaguchi A
J Oral Pathol Med; 2016 May; 45(5):356-64. PubMed ID: 26859422
[TBL] [Abstract][Full Text] [Related]
15. Oral squamous carcinoma cells secrete RANKL directly supporting osteolytic bone loss.
Zhang X; Junior CR; Liu M; Li F; D'Silva NJ; Kirkwood KL
Oral Oncol; 2013 Feb; 49(2):119-28. PubMed ID: 22989723
[TBL] [Abstract][Full Text] [Related]
16. Molecular pathways involved in crosstalk between cancer cells, osteoblasts and osteoclasts in the invasion of bone by oral squamous cell carcinoma.
Quan J; Zhou C; Johnson NW; Francis G; Dahlstrom JE; Gao J
Pathology; 2012 Apr; 44(3):221-7. PubMed ID: 22406484
[TBL] [Abstract][Full Text] [Related]
17. A novel function of CXCL13 to stimulate RANK ligand expression in oral squamous cell carcinoma cells.
Yuvaraj S; Griffin AC; Sundaram K; Kirkwood KL; Norris JS; Reddy SV
Mol Cancer Res; 2009 Aug; 7(8):1399-407. PubMed ID: 19671684
[TBL] [Abstract][Full Text] [Related]
18. TAF1L promotes development of oral squamous cell carcinoma via decreasing autophagy-dependent apoptosis.
Wang D; Qi H; Zhang H; Zhou W; Li Y; Li A; Liu Q; Wang Y
Int J Biol Sci; 2020; 16(7):1180-1193. PubMed ID: 32174793
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of autophagy initiation: A novel strategy for oral squamous cell carcinomas.
Abd El-Aziz YS; McKay MJ; Molloy MP; McDowell B; Moon E; Sioson L; Sheen A; Chou A; Gill AJ; Jansson PJ; Sahni S
Biochim Biophys Acta Mol Cell Res; 2024 Feb; 1871(2):119627. PubMed ID: 37963518
[TBL] [Abstract][Full Text] [Related]
20. Up-regulation of survivin in oral squamous cell carcinoma correlates with poor prognosis and chemoresistance.
Su L; Wang Y; Xiao M; Lin Y; Yu L
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 Oct; 110(4):484-91. PubMed ID: 20868995
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
